Latest filing published 03 Nov 2025 for BioXcel Therapeutics, Inc..
Insider track record
No signal scores available.
David J. Mack: trading record in brief
David J. Mack is a declared insider of BioXcel Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 13 filings, for trades running from 30 November 2024 to 31 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 3 November 2025: an option exercise, in BioXcel Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David J. Mack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,694 sharesCommon StockSEC:0001104659-25-105760:0
- 1,694 sharesCommon StockSEC:0001104659-25-095739:0
- 1,693 sharesCommon StockSEC:0001104659-25-086528:0
- 1,693 sharesCommon StockSEC:0001104659-25-072701:0
- 1,693 sharesCommon StockSEC:0001104659-25-064148:0
- 1,693 sharesCommon StockSEC:0001104659-25-055610:0
- 1,693 sharesCommon StockSEC:0001104659-25-043628:0
- 1,693 sharesCommon StockSEC:0001104659-25-030679:0
- 1,693 sharesCommon StockSEC:0001104659-25-020519:0
- 27,089 sharesCommon StockSEC:0001104659-25-009204:0
- 27,089 sharesCommon StockSEC:0001104659-25-000782:0
- 27,089 sharesCommon StockSEC:0001104659-24-125506:0
- 27,089 sharesCommon StockSEC:0001104659-24-125073:0
13 of 13 declarations